Inovio Halts Head And Neck Cancer Trial On Safety Concerns
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm prematurely stopped a pivotal oncology study investigating its tumor ablation technology after an independent data monitoring committee raised concerns about adverse events.